10 /100
LOW RISK
Score updated Jul 13, 2026

BF-B — Brown-Forman Corporation Dilution Risk Tracker

Track BF-B dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track BF-B — Get alerts when the score changes →

As of July 13, 2026, Brown-Forman Corporation (BF-B) has a DilutionWatch DilutionScore of 10/100, rated LOW dilution risk. Brown-Forman Corporation has a market capitalization of $11.80B, 472.67M shares outstanding, 586 institutional holders tracked. Key dilution vectors include approximately 999 months of cash runway.

Source: DilutionWatch (dilutionwatch.com) — data updated daily from SEC EDGAR filings. Not financial advice.

📊 Score Breakdown

📋 Offering Ability
20
💰 Cash Runway
0
📊 Float Risk
7
⚠️ Warrant Exposure
15
🔄Convertible Debt

🌦️ Dilution Forecast

☀️
Clear
No significant dilution signals
0%
No significant dilution signals detected for BF-B.
🔔 Track BF-B — Get forecast alerts →

💹 Market Data

Market Cap$11.80B
Shares Outstanding472.67M
FloatN/A
Cash$308.00M
Debt$2.43B
Short InterestN/A

🏛 Institutional Holdings

QoQ: ↑ 6.9% shares (2026Q1 vs prior)
586 institutional holders · 248.37M shares
#1 VANGUARD CAPITAL MANAGEMENT LLC 29.34M shares
#2 MORGAN STANLEY 15.31M shares
#3 VANGUARD PORTFOLIO MANAGEMENT LLC 13.33M shares
+ 17 more holders Sign up free to view →

📉 Short Interest

Short interest data updating...

📁 Recent SEC Activity

4 INSIDER TRANSACTION Feb 13, 2026
Full SEC filing analysis available with free account

📰 Recent News

No recent news

📋 What This Means for BF-B Shareholders

Brown-Forman Corporation (BF-B) has a DilutionScore of 10/100, rated Low dilution risk. At this score level, DilutionWatch's real-time EDGAR monitoring shows limited near-term dilution signals. This does not mean zero dilution risk — shelf registrations can be filed and activated quickly — but the current filing profile shows no major outstanding dilution programs. Score as of July 13, 2026.

DilutionWatch's EDGAR monitoring for BF-B shows no major active dilution programs at this time. The primary risk categories — shelf registration capacity, ATM programs, warrant overhang, and cash runway — are each within normal ranges for a company of this profile. This can change quickly if a new S-3 or Form S-1 is filed.

DilutionWatch tracks over 25 SEC filing types for BF-B in real-time, scanning EDGAR every 60 seconds. The DilutionWatch screener shows real-time score changes for BF-B alongside comparable low-risk stocks. Not financial advice — this analysis is for informational purposes only.

Track BF-B Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking BF-B — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required

🔗 Related Stocks — LOW Risk

Other LOW dilution risk stocks tracked by DilutionWatch with similar profiles:

Browse all 7,800+ tracked stocks →

📖 Dilution Education
→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations
🔬 More Research for BF-B
📊 BF-B FDA Catalyst Timeline & Biotech Grade — BiotechSigns 📡 BF-B Signal Convergence & Dark Pool Activity — StonkWhisper

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.